English | 简体中文 | 繁體中文 | 한국어 | 日本語
 Multimedia Press Releases
Mitsubishi Shipbuilding Successfully Separates and Captures CO2 from Exhaust Gas in World's First Marine-based CO2 Capture System Project
Mitsubishi Shipbuilding Successfully Separates and Captures CO2 from Exhaust Gas in World's First Marine-based CO2 Capture System Project
October 20 2021, 14:55 HKT
more details
Moonstake, 2021년 11월 1일 파트너 TRON 재단과 공동 웨비나 개최
Moonstake, 2021년 11월 1일 파트너 TRON 재단과 공동 웨비나 개최
October 20 2021, 15:00 HKT
more details
Moonstake、2021年11月1日にパートナーであるTRON財団と共同でウェビナーを開催
Moonstake、2021年11月1日にパートナーであるTRON財団と共同でウェビナーを開催
October 20 2021, 15:00 HKT
more details
Moonstake to Host Joint Webinar with Partner TRON Foundation on 1 Nov 2021
Moonstake to Host Joint Webinar with Partner TRON Foundation on 1 Nov 2021
October 20 2021, 15:00 HKT
more details
All-New Outlander PHEV Model Wins the Good Design Award 2021 in Japan
All-New Outlander PHEV Model Wins the Good Design Award 2021 in Japan
October 20 2021, 14:36 HKT
more details
Initiative to Enhance Cooperation of China and Central Asian Countries Concludes
Initiative to Enhance Cooperation of China and Central Asian Countries Concludes
October 22 2021, 17:00 HKT
more details
Freedom Business Summit 2021 Online Will Bring Together 2000+ Worldwide Freedom Business Entrepreneurs
Freedom Business Summit 2021 Online Will Bring Together 2000+ Worldwide Freedom Business Entrepreneurs
October 20 2021, 10:07 HKT
more details
Seven autumn trade fairs open next Wednesday
Seven autumn trade fairs open next Wednesday
October 20 2021, 05:00 HKT
more details
Seven autumn trade fairs open next Wednesday
Seven autumn trade fairs open next Wednesday
October 20 2021, 05:00 HKT
more details
Seven autumn trade fairs open next Wednesday
Seven autumn trade fairs open next Wednesday
October 20 2021, 05:00 HKT
more details
科軒動力向菲律賓交付超過70輛電動小巴
科軒動力向菲律賓交付超過70輛電動小巴
October 19 2021, 19:11 HKT
more details
科軒動力向菲律賓交付超過70輛電動小巴
科軒動力向菲律賓交付超過70輛電動小巴
October 19 2021, 19:11 HKT
more details
科軒動力向菲律賓交付超過70輛電動小巴
科軒動力向菲律賓交付超過70輛電動小巴
October 19 2021, 19:11 HKT
more details
Ev Dynamics Delivers Over 70 Electric Minibuses to the Philippines
Ev Dynamics Delivers Over 70 Electric Minibuses to the Philippines
October 19 2021, 19:10 HKT
more details
Ev Dynamics Delivers Over 70 Electric Minibuses to the Philippines
Ev Dynamics Delivers Over 70 Electric Minibuses to the Philippines
October 19 2021, 19:10 HKT
more details
Ev Dynamics Delivers Over 70 Electric Minibuses to the Philippines
Ev Dynamics Delivers Over 70 Electric Minibuses to the Philippines
October 19 2021, 19:10 HKT
more details
Launch of world-first expert resource to foster best practice osteoporosis care in the Asia Pacific
Launch of world-first expert resource to foster best practice osteoporosis care in the Asia Pacific
October 20 2021, 06:00 HKT
more details
Launch of world-first expert resource to foster best practice osteoporosis care in the Asia Pacific
Launch of world-first expert resource to foster best practice osteoporosis care in the Asia Pacific
October 20 2021, 06:00 HKT
more details
Mitsubishi Heavy Industries Engineering Successfully Completes Testing of New "KS-21" Solvent for CO2 Capture
Mitsubishi Heavy Industries Engineering Successfully Completes Testing of New
October 19 2021, 14:37 HKT
more details
Hitachi, Tohoku University and Kyoto University Become World's First to Establish Technology for Highly Efficient, High-quality Production of Actinium-225, a Material Required for Internal Radiation Therapy Called TAT
Hitachi, Tohoku University and Kyoto University Become World's First to Establish Technology for Highly Efficient, High-quality  Production of Actinium-225, a Material Required for Internal Radiation Therapy Called TAT
October 19 2021, 13:03 HKT
more details
Hitachi, Tohoku University and Kyoto University Become World's First to Establish Technology for Highly Efficient, High-quality Production of Actinium-225, a Material Required for Internal Radiation Therapy Called TAT
Hitachi, Tohoku University and Kyoto University Become World's First to Establish Technology for Highly Efficient, High-quality  Production of Actinium-225, a Material Required for Internal Radiation Therapy Called TAT
October 19 2021, 13:03 HKT
more details
糖尿病治疗及监测医疗器械提供商微泰医疗于香港联合交易所主板成功上市
糖尿病治疗及监测医疗器械提供商微泰医疗于香港联合交易所主板成功上市
October 19 2021, 13:13 HKT
more details
糖尿病治疗及监测医疗器械提供商微泰医疗于香港联合交易所主板成功上市
糖尿病治疗及监测医疗器械提供商微泰医疗于香港联合交易所主板成功上市
October 19 2021, 13:13 HKT
more details
糖尿病治療及監測醫療器械提供商微泰醫療於香港聯合交易所主板成功上市
糖尿病治療及監測醫療器械提供商微泰醫療於香港聯合交易所主板成功上市
October 19 2021, 13:12 HKT
more details
糖尿病治療及監測醫療器械提供商微泰醫療於香港聯合交易所主板成功上市
糖尿病治療及監測醫療器械提供商微泰醫療於香港聯合交易所主板成功上市
October 19 2021, 13:12 HKT
more details
グローバルな視点で世界を見る、TIENS26周年の素晴らしいショー
グローバルな視点で世界を見る、TIENS26周年の素晴らしいショー
October 20 2021, 12:00 HKT
more details
WARC, TikTok and Publicis Groupe release "From Discovery to Purchase: The Role of Community Commerce" a new study revealing the potential of creator-driven marketing for brand growth
WARC, TikTok and Publicis Groupe release
October 19 2021, 10:00 HKT
more details
Fujitsu and Aichi Cancer Center Develop AI System to Offer Patients Personalized Cancer Treatment
Fujitsu and Aichi Cancer Center Develop AI System to Offer Patients Personalized Cancer Treatment
October 19 2021, 09:28 HKT
more details
Avance Clinical臨床試驗合作申辦方XWPharma正式開啟其XW10508首次人類臨床試驗,研究快速緩解難治性抑鬱症以及慢性疼痛療法
Avance Clinical臨床試驗合作申辦方XWPharma正式開啟其XW10508首次人類臨床試驗,研究快速緩解難治性抑鬱症以及慢性疼痛療法
October 19 2021, 15:00 HKT
more details
Avance Clinical临床试验合作申办方XWPharma正式开启其XW10508首次人类临床试验,研究快速缓解难治性抑郁症以及慢性疼痛疗法
Avance Clinical临床试验合作申办方XWPharma正式开启其XW10508首次人类临床试验,研究快速缓解难治性抑郁症以及慢性疼痛疗法
October 19 2021, 15:00 HKT
more details
 ACN Search:
 
Spritzer EcoParks colourful Chinese New Year decorations light up the auspicious season, bringing festive cheer to all visitors
 
 Events:
More events >>
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575